This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Adverse Reactions Remove Labelling Remove Medical Schools Related Topics
Packaging Documentation Pharmaceutical Companies FDA Communication Pharmaceutical Companies Hospitals More Related Topics >
article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

SEPTEMBER 2, 2022

RMMs aim to optimise the safe and effective use of medical products in clinical practice by improving their risk-benefit balance. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. About the author. References.

Adverse Reactions 76
Adverse Reactions Documentation Medical Schools Packaging 76
article thumbnail

Antidepressants and Suicide: Why Don’t People Think There’s a Link?

The People's Pharmacy

JUNE 26, 2023

The drug was eventually outlawed, but only after thousands of adverse reactions and over a hundred deaths worldwide. ” “It would be disastrous if an antidepressant medication actually produced “obsessive, recurrent, persistent and intrusive” thoughts of suicide.

FDA 81
FDA Adverse Reactions Medical Schools Hospitals 81
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024